S19BP inhibitors represent a class of chemical compounds that target and modulate the activity of the S19-binding protein (S19BP), a key component involved in regulating various biochemical pathways. S19BP is a molecular entity that functions primarily as a binding partner within protein complexes, interacting with specific substrates to influence metabolic, enzymatic, or regulatory mechanisms within cells. The inhibitors of S19BP function by interfering with the binding dynamics between the protein and its associated substrates, often through direct binding to the active or allosteric sites of S19BP. This disruption can result in alterations to the downstream molecular processes that S19BP is involved in, affecting protein folding, cellular signaling, or catalytic activities within a variety of biochemical contexts. Inhibitors of this class may exhibit selectivity based on their structural compatibility with the binding pockets of S19BP, which are typically shaped by specific amino acid residues or motifs that contribute to its molecular recognition features.
At a chemical level, S19BP inhibitors often exhibit a range of structural diversity, but they are unified by their ability to modulate protein-protein interactions. Many of these inhibitors possess functional groups that mimic or compete with the natural substrates of S19BP, thereby preventing the formation of productive protein complexes. The design of such inhibitors typically involves the identification of molecular features such as hydrophobic pockets, hydrogen-bond donors and acceptors, or electrostatic interactions that facilitate binding. Advanced techniques like structure-based drug design (SBDD) and computational modeling are frequently used to optimize the affinity and specificity of these inhibitors. The chemical properties of S19BP inhibitors, including their solubility, stability, and binding kinetics, play significant roles in determining their efficiency in modulating the protein's biological functions. Through detailed characterization, S19BP inhibitors offer a fascinating avenue for studying the regulatory mechanisms governed by this protein in various biological systems.
SEE ALSO...
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Cycloheximide | 66-81-9 | sc-3508B sc-3508 sc-3508A | 100 mg 1 g 5 g | $41.00 $84.00 $275.00 | 127 | |
Inhibits eukaryotic protein synthesis by interfering with the translocation step in ribosomes, potentially affecting RPS19BP1. | ||||||
Rapamycin | 53123-88-9 | sc-3504 sc-3504A sc-3504B | 1 mg 5 mg 25 mg | $63.00 $158.00 $326.00 | 233 | |
Inhibits mTOR, a key regulator of protein synthesis, possibly influencing RPS19BP1 through global protein synthesis control. | ||||||
Chloramphenicol | 56-75-7 | sc-3594 | 25 g | $90.00 | 10 | |
Binds to bacterial ribosomes, inhibiting protein synthesis; could indirectly affect RPS19BP1 in similar eukaryotic contexts. | ||||||
Puromycin dihydrochloride | 58-58-2 | sc-108071 sc-108071B sc-108071C sc-108071A | 25 mg 250 mg 1 g 50 mg | $42.00 $214.00 $832.00 $66.00 | 394 | |
Causes premature chain termination in protein synthesis; could impact RPS19BP1 indirectly by disrupting ribosomal activity. | ||||||
Emetine | 483-18-1 | sc-470668 sc-470668A sc-470668B sc-470668C | 1 mg 10 mg 50 mg 100 mg | $440.00 $900.00 $1400.00 $2502.00 | ||
Inhibits protein synthesis in eukaryotes, potentially affecting RPS19BP1 function by blocking ribosomal translocation. | ||||||
Tetracycline | 60-54-8 | sc-205858 sc-205858A sc-205858B sc-205858C sc-205858D | 10 g 25 g 100 g 500 g 1 kg | $63.00 $94.00 $270.00 $417.00 $634.00 | 6 | |
Binds to the 30S subunit of bacterial ribosomes; its mechanism could indirectly affect RPS19BP1 in eukaryotes. | ||||||
Anisomycin | 22862-76-6 | sc-3524 sc-3524A | 5 mg 50 mg | $99.00 $259.00 | 36 | |
Inhibits peptide elongation in eukaryotic ribosomes, possibly impacting RPS19BP1 by disrupting ribosomal assembly. | ||||||
Actinomycin D | 50-76-0 | sc-200906 sc-200906A sc-200906B sc-200906C sc-200906D | 5 mg 25 mg 100 mg 1 g 10 g | $74.00 $243.00 $731.00 $2572.00 $21848.00 | 53 | |
Interferes with DNA-dependent RNA synthesis, potentially impacting RPS19BP1 by affecting ribosomal RNA synthesis. | ||||||
Phleomycin | 11006-33-0 | sc-204845 sc-204845A | 5 mg 25 mg | $195.00 $495.00 | ||
Inhibits peptidyl transferase activity in ribosomes, potentially affecting RPS19BP1's role in ribosome function. | ||||||
Chondroitin Sulfate, Bovine | 9007-28-7 | sc-203888 | 5 g | $94.00 | 1 | |
Inactivates eukaryotic elongation factor 2 (EF-2), possibly affecting RPS19BP1 by disrupting protein synthesis processes. | ||||||